Next Steps for Immunotherapy in Glioblastoma

Research output: Contribution to journalReview articlepeer-review

Abstract

Outcomes for glioblastoma (GBM) patients undergoing standard of care treatment remain poor. Here we discuss the portfolio of previously investigated immunotherapies for glioblastoma, including vaccine therapy and checkpoint inhibitors, as well as novel emerging therapeutic approaches. In addition, we explore the factors that potentially influence response to immunotherapy, which should be considered in future research aimed at improving immunotherapy efficacy.

Original languageEnglish (US)
Article number4023
JournalCancers
Volume14
Issue number16
DOIs
StatePublished - Aug 2022

Keywords

  • glioblastoma
  • immune system
  • immunotherapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Next Steps for Immunotherapy in Glioblastoma'. Together they form a unique fingerprint.

Cite this